An NSF International Company 
Revision of EU GMP Chapter 6 - Quality Control
The final version of a revised Chapter 6 was published in late March 2014 and becomes effective from 1 October 2014. The final version is almost identical to the draft revision that was published on 17 January 2013. This revision adds more empha...
Read more
FDA has published new guidance that describes chemistry, manufacturing, and controls (CMC) post-approval manufacturing changes that should be documented in an annual report.
This guidance consists of two lists published as Appendices. The first list, Appendix A, was developed using a risk-ba...
Read more
The medical device industry faces dramatic changes in the way it is regulated, particularly in Europe. James Pink, Vice President Europe of NSF Health Sciences, discusses the challenges facing the quality professional.
Download the full article pdf
As featured in the April issue of Quality W...
Read more
On 2 April 2025 the text of the new CT Regulation, which will replace the CT Directive 2001/20/EC, was approved by the European Parliament. The regulation is expected to be published in the Official Journal by mid-2014 and become effective in mid-2016.
Read moreTo improve timely patient access to new medicines, the European Medicines Agency (EMA) launched a pilot project that employs an adaptive licensing approach to real medicines in development.
Adaptive licensing, sometimes called staggered approval or progressive licensing, is a prospectively pla...
Read more